Insider Transactions Reported by 25 Insiders of Serina Therapeutics, Inc.

Symbol
SER on NYSE
Location
Huntsville, AL

Insiders trading volume in the past year

Serina Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Juvenescence Ltd 10%+ Owner $60,343,760 06 Jun 2024
Juvenescence US Corp. Director, 10%+ Owner $9,704,025 14 Mar 2023
Gregory H. Bailey Director $4,258,638 07 Nov 2025
Steven A. Ledger Chief Executive Officer, Director $957,300 03 Feb 2026
Jay R. Venkatesan Director $500,000 07 Nov 2025
Steven Mintz Director $247,311 12 Sep 2024
Tacey Viegas COO and Secretary $34,580 26 Mar 2024
Michael D. West Chief Executive Officer $24,769 11 Mar 2023
Randall Moreadith Chief Scientific Officer $0 -$1,003,646 -100% 03 Feb 2026
NAFEES NASEER MALIK Chief Operating Officer 04 Jun 2021
Hal Sternberg Vice President-Research 04 Jun 2021
Jean-Christophe Renondin Director 09 Aug 2023
Michael H. May Director 21 Jun 2021
J. MILTON HARRIS Director 01 Apr 2024
Remy Gross Director 01 Apr 2024
Joanne M. Hackett Director 02 Feb 2022
Annalisa Jenkins Director 21 Jun 2021
Judith Segall Director of Admin & Secretary 04 Jun 2021
Andrea E. Park Chief Financial Officer 04 Jun 2021
Simba Gill Director 03 Feb 2026
Gregory S. Curhan Chief Financial Officer 15 Aug 2024
Srini Tenjarla SVP, CMC & Formulation 03 Feb 2026
KAREN J. WILSON Director 07 Nov 2025
Stephen K. Brannan Director 07 Nov 2025
Marshall Richard Peter Director 07 Nov 2025

Recent Insider Transactions by Companies or Individuals for Serina Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.